Fact CheckerSign in

NCT05377307Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

Long-term Follow-up Study to Evaluate the Safety and Efficacy in Patients Who Have Ever Received Lentiviral-based Gene-edited Immune Cell Therapy

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

According to health authorities guidances (FDA 2006, EMA(European Medicines Agency) 2009) for gene therapy clinical trials, observing subjects for delayed adverse events for 15 years is recommended. This purpose of this long-term follow-up study is to evaluate the safety and efficacy in patients who have ever received lentiviral-based gene-edited immune cells which are manufactured by Pell Bio-Med Technology Co. Ltd.

Status (registry)
Recruiting
Study type
Observational
Enrollment
49 (estimated)
First submitted
12 May 2022
Start date
31 Mar 2023
Primary completion date
Dec 2036
Lead sponsor
Pell Bio-Med Technology Co., Ltd.
NCT number
NCT05377307

What you commit to

  • Study type: Observational
  • Planned participants: 49
  • From 31 Mar 2023 to the primary completion date, Dec 2036
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • There are no specific exclusion criteria for this study.

Who the study is looking for

  • Patients must have ever received Pell's lentiviral-based gene-edited immune cell as monotherapy or as combination therapy in clinical trials.
  • The last lentiviral-based gene-edited immune cell infusion within 15 years.
  • Patient/patient's parent/legal guardian is capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kaohsiung Medical University Chung-Ho Memorial Hospital
Coordinator of this site? Confirm its status
KaohsiungTaiwanRecruiting
Chi Mei Medical Center
Coordinator of this site? Confirm its status
TainanTaiwanRecruiting
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting
Taipei Medical University - Taipei Medical University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting
Taipei Veterans General Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.